0.03Open0.10Pre Close31 Volume2.02K Open Interest60.00Strike Price66.00Turnover118.40%IV19.33%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0117Delta0.0043Gamma2478.00Leverage Ratio-0.0272Theta-0.0001Rho-29.05Eff Leverage0.0019Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet